July 10, 2026 · Form 4 insider transaction
Mazumdar Claire bought 10,000 shares of Bicara Therapeutics Inc. at $3.79 per share, a transaction worth $37.9K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 4 days after the transaction.
This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on March 31, 2026.